---
task_id: epic-phase16
task_class: T2
plan: docs/plans/epic-phase16.md
reviewer: critic
date: 2026-06-29
recommendation: approve
---

## Plan adherence

score: 9
notes: All 10 acceptance criteria met. Monte Carlo interpretation correctly deferred per plan.

## Findings

| ID | Severity | Area | Finding | Suggested fix |
|----|----------|------|---------|---------------|
| F1 | low | validation/validate.py | `_resolve_envelope` name-matching heuristics are brittle for new scenarios | Add explicit `envelope_key` in scenario YAML in Phase 17 |

## Checks

- [x] Tests cover acceptance criteria
- [x] No scope beyond plan
- [x] Contracts updated if interfaces changed
- [x] Section AGENT.md updated or N/A stated
- [x] Security: no secrets, safe subprocess/network
- [x] Performance: no obvious regression on year-long sim

## Summary

Phase 16 delivers `reference/benchmarks.yaml`, validation module, `--validate` CLI, interpretation
v2 (references + actions), and study report extensions. 183 tests green. One low finding on
envelope name heuristics; acceptable for v1.2.0. Approve.